Hepatocyte apoptosis and fas expression are prominent features of human nonalcoholic steatohepatitis.

[1]  Brian P. Mulhall,et al.  Nonalcoholic steatohepatitis , 2004, Current treatment options in gastroenterology.

[2]  G. Gores,et al.  Apoptotic Body Engulfment by a Human Stellate Cell Line Is Profibrogenic , 2003, Laboratory Investigation.

[3]  G. Gores,et al.  Fas enhances fibrogenesis in the bile duct ligated mouse: a link between apoptosis and fibrosis. , 2002, Gastroenterology.

[4]  G. Gores,et al.  Death receptor-mediated apoptosis and the liver. , 2002, Journal of hepatology.

[5]  R. Karim,et al.  NASH and insulin resistance: Insulin hypersecretion and specific association with the insulin resistance syndrome , 2002, Hepatology.

[6]  J. Maher,et al.  Anti-Fas Induces Hepatic Chemokines and Promotes Inflammation by an NF-κB-independent, Caspase-3-dependent Pathway* , 2001, The Journal of Biological Chemistry.

[7]  C. Poremba,et al.  Caspase activation correlates with the degree of inflammatory liver injury in chronic hepatitis C virus infection , 2001, Hepatology.

[8]  A. Diehl.  Nonalcoholic fatty liver disease: implications for alcoholic liver disease pathogenesis. , 2001, Alcoholism, clinical and experimental research.

[9]  M. Ziol,et al.  Clinical and biological relevance of hepatocyte apoptosis in alcoholic hepatitis. , 2001, Journal of hepatology.

[10]  G. Farrell,et al.  Etiopathogenesis of Nonalcoholic Steatohepatitis , 2001, Seminars in liver disease.

[11]  K. Batts,et al.  Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis , 1999, Hepatology.

[12]  G. Gores,et al.  Hepatocyte apoptosis after bile duct ligation in the mouse involves Fas. , 1999, Gastroenterology.

[13]  B. Neuschwander‐Tetri,et al.  Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions , 1999, American Journal of Gastroenterology.

[14]  V. Dixit,et al.  Death receptors: signaling and modulation. , 1998, Science.

[15]  Junying Yuan,et al.  Cleavage of BID by Caspase 8 Mediates the Mitochondrial Damage in the Fas Pathway of Apoptosis , 1998, Cell.

[16]  E. Lara-Pezzi,et al.  Inducible nitric oxide synthase expression in chronic viral hepatitis. Evidence for a virus-induced gene upregulation. , 1998, The Journal of clinical investigation.

[17]  P. Galle,et al.  CD95-induced apoptosis in human liver disease. , 1998, Seminars in liver disease (Print).

[18]  D. Loo,et al.  Measurement of cell death. , 1998, Methods in cell biology.

[19]  J. Savill.  Apoptosis in resolution of inflammation , 1997, Journal of leukocyte biology.

[20]  P. Galle,et al.  Involvement of the CD95 (APO-1/Fas) receptor and ligand in liver damage , 1995, The Journal of experimental medicine.

[21]  C. Thompson,et al.  Apoptosis in the pathogenesis and treatment of disease , 1995, Science.

[22]  W. Bursch,et al.  Active cell death (apoptosis) in liver biology and disease. , 1995, Progress in liver diseases.

[23]  Randall G. Lee,et al.  Nonalcoholic steatohepatitis: a study of 49 patients. , 1989, Human pathology.

[24]  K. Ishak,et al.  Alcohollike liver disease in nonalcoholics. A clinical and histologic comparison with alcohol-induced liver injury. , 1988, Gastroenterology.

[25]  F. Schaffner,et al.  Nonalcoholic fatty liver disease. , 1986, Progress in liver diseases.

[26]  J. Ludwig,et al.  Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease. , 1980, Mayo Clinic proceedings.